Cargando…

Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel Therapies

Thalassemia is a heterogeneous congenital hemoglobinopathy common in the Mediterranean region, Middle East, Indian subcontinent, and Southeast Asia with increasing incidence in Northern Europe and North America due to immigration. Iron overloading is one of the major long-term complications in patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Pei-Chin, Hsu, Wan-Yi, Lee, Po-Yi, Hsu, Shih-Hsien, Chiou, Shyh-Shin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454908/ https://www.ncbi.nlm.nih.gov/pubmed/37628834 http://dx.doi.org/10.3390/ijms241612654

Ejemplares similares

Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial–Mesenchymal Transition
por: Chuang, Kai-Ting, et al.
Publicado: (2023)

New Insights Into Pathophysiology of β-Thalassemia
por: Sanchez-Villalobos, Maria, et al.
Publicado: (2022)

Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients
por: Jang, Tyng-Yuan, et al.
Publicado: (2017)

Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma
por: Wang, Li-Ting, et al.
Publicado: (2016)

Correction: Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma
por: Wang, Li-Ting, et al.
Publicado: (2018)

Plasma levels of IL-1β and IL-37 in patients with severe haemophilia
por: Lin, Pei-Chin, et al.
Publicado: (2020)

Thalassemia and hepatocellular carcinoma: links and risks
por: Marsella, Maria, et al.
Publicado: (2019)

Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis
por: Finianos, Antoine, et al.
Publicado: (2018)

Modification of Epigenetic Histone Acetylation in Hepatocellular Carcinoma
por: Liu, Kwei-Yan, et al.
Publicado: (2018)

Homeobox Genes and Hepatocellular Carcinoma
por: Liu, Kwei-Yan, et al.
Publicado: (2019)

Pathophysiology and treatment of patients with beta-thalassemia – an update
por: Fibach, Eitan, et al.
Publicado: (2017)

Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma
por: Su, Yung-Yeh, et al.
Publicado: (2022)

Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma
por: Liao, Chen-Yi, et al.
Publicado: (2015)

Aryl hydrocarbon receptor–kynurenine axis promotes oncogenic activity in BCP-ALL
por: Wang, Li-Ting, et al.
Publicado: (2022)

Evidence-based medicine and Management of Hepatocellular Carcinoma in Thalassemia
por: Mancuso, Andrea
Publicado: (2020)

Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging
por: Moawad, Ahmed W, et al.
Publicado: (2020)

Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System
por: Hsu, Chia-Yang, et al.
Publicado: (2015)

Prognosticators of hepatocellular carcinoma with intrahepatic vascular invasion
por: Lo, Yuan-Chen, et al.
Publicado: (2019)

Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis
por: Liu, Po-Hong, et al.
Publicado: (2014)

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
por: Yu, Chun-Yen, et al.
Publicado: (2023)

Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment
por: De Sanctis, Vincenzo, et al.
Publicado: (2018)

Using Serum α-Fetoprotein for Prognostic Prediction in Patients with Hepatocellular Carcinoma: What is the Most Optimal Cutoff?
por: Hsu, Chia-Yang, et al.
Publicado: (2015)

Prognostic Factors for Pulmonary Metastasectomy in Hepatocellular Carcinoma
por: Kuo, Shuenn-Wen, et al.
Publicado: (2006)

Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
por: Chen, Bang-Bin, et al.
Publicado: (2021)

Decrypting Cryptogenic Hepatocellular Carcinoma: Clinical Manifestations, Prognostic Factors and Long-Term Survival by Propensity Score Model
por: Hsu, Chia-Yang, et al.
Publicado: (2014)

When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy
por: Liu, Po-Hong, et al.
Publicado: (2015)

Metastasis-associated protein 2 regulates human hepatocellular carcinoma metastasis progression through modulating p38MAPK/MMP2 pathways
por: Hsu, Wen-Hung, et al.
Publicado: (2019)

Onco-proteogenomics identifies urinary S100A9 and GRN as potential combinatorial biomarkers for early diagnosis of hepatocellular carcinoma
por: Huang, Chun-Hao, et al.
Publicado: (2015)

Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
por: Ho, Shu-Yein, et al.
Publicado: (2018)

Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma
por: Bannaga, Ayman, et al.
Publicado: (2021)

Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology
por: Liu, Po-Hong, et al.
Publicado: (2015)

Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy
por: Huo, Teh I, et al.
Publicado: (2010)

Role of modern radiotherapy in managing patients with hepatocellular carcinoma
por: Chen, Liang-Cheng, et al.
Publicado: (2021)

Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients
por: Wang, Po-Ming, et al.
Publicado: (2014)

Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma
por: Hsu, Chia-Yang, et al.
Publicado: (2018)

The Relationship Between Zebrin Expression and Cerebellar Functions: Insights From Neuroimaging Studies
por: Lin, Yi-Cheng, et al.
Publicado: (2020)

New Insights into the Role of miR-29a in Hepatocellular Carcinoma: Implications in Mechanisms and Theragnostics
por: Yang, Ya-Ling, et al.
Publicado: (2021)

Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence
por: Mangia, Alessandra, et al.
Publicado: (2020)

Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study
por: Hsu, Chia-Yang, et al.
Publicado: (2017)

In Vitro Study of Ineffective Erythropoiesis in Thalassemia: Diverse Intrinsic Pathophysiological Features of Erythroid Cells Derived from Various Thalassemia Syndromes
por: Kaewsakulthong, Woratree, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ca2k0fi4baro2okc9i9k2rmup